Worth reading
43Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
156400
Shares (number of shares underlying the share subscription rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of share acquisition rights as stock options
Who receives how much
First Series: 51,400 shares; Second Series: 105,000 shares (total: 156,400 shares)
Directors of the companyFirst Series: 1 person; Second Series: 1 person / First Series: 51,400 shares; Second Series: 25,000 shares
Executive officers of the Company4 / 80,000 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
No consideration per stock acquisition right
Terms of the stock acquisition rights
Exercise price
¥1,000 per share for both the First and Second Series. Adjustment provisions and floor: Not disclosed
Exercise period
First Series: from 1 August 2030 to 31 July 2034; Second Series: from 1 August 2030 to 31 July 2032
Number of Stock Acquisition Rights
First Series: 514; Second Series: 1,050; total: 1,564. Remaining unexercised rights: Not disclosed
Categories and Number of Persons Covered
First Series: 1 director of the Company, 514 rights (51,400 shares). Second Series: 1 director of the Company, 250 rights (25,000 shares), and 4 executive officers of the Company, 800 rights (80,000 shares)
Payment date
No monetary payment is required in exchange for the stock acquisition rights.
Procedures under the Corporate Code of Conduct
Approved at the annual general meeting of shareholders held on 24 June 2026. The issuance was resolved at the Board of Directors meeting held on 22 July 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options |
| Number of shares to be issued or disposed of | First Series: 51,400 shares; Second Series: 105,000 shares (total: 156,400 shares) |
| Issue price and disposal price | No consideration per stock acquisition right |
| Payment date | No monetary payment is required in exchange for the stock acquisition rights. |
| Intended allottee | Category Directors of the company / Number of Employees First Series: 1 person; Second Series: 1 person / Number of Shares First Series: 51,400 shares; Second Series: 25,000 shares, Category Executive officers of the Company / Number of Employees 4 / Number of Shares 80,000 shares |
| Exercise price | ¥1,000 per share for both the First and Second Series. Adjustment provisions and floor: Not disclosed |
| Exercise period | First Series: from 1 August 2030 to 31 July 2034; Second Series: from 1 August 2030 to 31 July 2032 |
| Number of Stock Acquisition Rights | First Series: 514; Second Series: 1,050; total: 1,564. Remaining unexercised rights: Not disclosed |
| Categories and Number of Persons Covered | First Series: 1 director of the Company, 514 rights (51,400 shares). Second Series: 1 director of the Company, 250 rights (25,000 shares), and 4 executive officers of the Company, 800 rights (80,000 shares) |
| Procedures under the Corporate Code of Conduct | Approved at the annual general meeting of shareholders held on 24 June 2026. The issuance was resolved at the Board of Directors meeting held on 22 July 2026 |
Items this document does not state (18)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To motivate directors and employees of the Company and its subsidiaries to improve performance, boost morale, secure talented personnel, and contribute to enhancing the corporate value of the Group as a whole.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.